EUVIMEDEUVIMED entdecken
Kommentar

Once-daily roflumilast foam for treating scalp and body psoriasis

British Journal of Dermatology · 2023

DOI: 10.1093/bjd/ljad297 ↗

Kurz gefasst

Kommentar in der Zeitschrift British Journal of Dermatology, 2023. Hauptthemen laut MEDLINE: Scalp, Psoriasis, Phosphodiesterase 4 Inhibitors.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ScalpPsoriasisPhosphodiesterase 4 InhibitorsHumansAminopyridinesBenzamidesCyclopropanes

Substanzen

Phosphodiesterase 4 InhibitorsRoflumilastAminopyridinesBenzamidesCyclopropanes

Zitieren

APA

(2023). Once-daily roflumilast foam for treating scalp and body psoriasis. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljad297

Vancouver

Once-daily roflumilast foam for treating scalp and body psoriasis. British Journal of Dermatology. 2023. doi:10.1093/bjd/ljad297

BibTeX
@article{euvimed2023,
  title = {Once-daily roflumilast foam for treating scalp and body psoriasis},
  journal = {British Journal of Dermatology},
  year = {2023},
  doi = {10.1093/bjd/ljad297}
}
Kostenlos starten →